Geopolitical cost headwinds
Input cost inflation and logistics disruptions from geopolitical tensions may not be fully recovered from customers in a timely manner, pressuring margins.
medium · management_commentarySai Life Sciences Limited — Q4 FY26
Sai Life Sciences delivered a strong FY26 with 29% revenue growth, 56% EBITDA growth, and 109% PAT growth, driven by deepening large pharma relationships (19 of top 25, contribu...
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Execution risk from rapid capex scale-up
Doubling capex to ₹1,100-1,300 crore could strain organizational capability and lead to inefficiencies, as flagged by an analyst question on execution fragility.
high · analyst_questionNew modalities revenue decline
Revenue from new modalities fell from 7% to 4% of total, indicating lumpiness in clinical-stage campaigns and potential competitive pressure.
medium · data_observationCustomer concentration risk
Top 10 customers contribute 54% of revenue; loss of any key customer could materially impact results.
medium · management_commentary